VITALHUB CORP (VHI.CA) Fundamental Analysis & Valuation

TSX:VHI • CA92847V5018

7.75 CAD
-0.35 (-4.32%)
Last: Mar 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VHI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

VHI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. While VHI has a great profitability rating, there are some minor concerns on its financial health. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make VHI a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. VHI.CA Profitability Analysis

1.1 Basic Checks

  • VHI had positive earnings in the past year.
  • In the past year VHI had a positive cash flow from operations.
  • In multiple years VHI reported negative net income over the last 5 years.
  • Of the past 5 years VHI 4 years had a positive operating cash flow.
VHI.CA Yearly Net Income VS EBIT VS OCF VS FCFVHI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

1.2 Ratios

  • VHI has a better Return On Assets (0.76%) than 90.00% of its industry peers.
  • VHI's Return On Equity of 1.08% is amongst the best of the industry. VHI outperforms 90.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.86%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 2.16%.
Industry RankSector Rank
ROA 0.76%
ROE 1.08%
ROIC 2.86%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
VHI.CA Yearly ROA, ROE, ROICVHI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • With an excellent Profit Margin value of 2.88%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • VHI's Operating Margin of 12.47% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
  • VHI's Operating Margin has improved in the last couple of years.
  • VHI's Gross Margin of 80.92% is amongst the best of the industry. VHI outperforms 90.00% of its industry peers.
  • In the last couple of years the Gross Margin of VHI has grown nicely.
Industry RankSector Rank
OM 12.47%
PM (TTM) 2.88%
GM 80.92%
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
VHI.CA Yearly Profit, Operating, Gross MarginsVHI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. VHI.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
  • VHI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VHI has been increased compared to 5 years ago.
  • The debt/assets ratio for VHI has been reduced compared to a year ago.
VHI.CA Yearly Shares OutstandingVHI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VHI.CA Yearly Total Debt VS Total AssetsVHI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • VHI has an Altman-Z score of 3.48. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.48, VHI is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
  • The Debt to FCF ratio of VHI (0.13) is better than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that VHI is not too dependend on debt financing.
  • The Debt to Equity ratio of VHI (0.00) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.13
Altman-Z 3.48
ROIC/WACC0.33
WACC8.64%
VHI.CA Yearly LT Debt VS Equity VS FCFVHI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of VHI (1.94) is better than 70.00% of its industry peers.
  • VHI has a Quick Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
  • VHI's Quick ratio of 1.94 is fine compared to the rest of the industry. VHI outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
VHI.CA Yearly Current Assets VS Current LiabilitesVHI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VHI.CA Growth Analysis

3.1 Past

  • VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
  • The Revenue has grown by 59.34% in the past year. This is a very strong growth!
  • Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 71.24% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.64% on average per year.
EPS Next Y-0.8%
EPS Next 2Y88.97%
EPS Next 3Y71.24%
EPS Next 5YN/A
Revenue Next Year60.02%
Revenue Next 2Y38.73%
Revenue Next 3Y27.64%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VHI.CA Yearly Revenue VS EstimatesVHI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
VHI.CA Yearly EPS VS EstimatesVHI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

5

4. VHI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 129.17, VHI can be considered very expensive at the moment.
  • VHI's Price/Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
  • VHI is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • VHI is valuated quite expensively with a Price/Forward Earnings ratio of 31.00.
  • 90.00% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (23.84), we can say VHI is valued slightly more expensively.
Industry RankSector Rank
PE 129.17
Fwd PE 31
VHI.CA Price Earnings VS Forward Price EarningsVHI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 40.22
EV/EBITDA 17.87
VHI.CA Per share dataVHI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The decent profitability rating of VHI may justify a higher PE ratio.
  • VHI's earnings are expected to grow with 71.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.97%
EPS Next 3Y71.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VHI.CA Dividend Analysis

5.1 Amount

  • VHI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VHI.CA Fundamentals: All Metrics, Ratios and Statistics

VITALHUB CORP

TSX:VHI (3/13/2026, 7:00:00 PM)

7.75

-0.35 (-4.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners40.42%
Inst Owner ChangeN/A
Ins Owners11.36%
Ins Owner ChangeN/A
Market Cap490.03M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.43
Price Target14.61 (88.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-5.22%
PT rev (3m)-5.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)5.77%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 129.17
Fwd PE 31
P/S 4.99
P/FCF 40.22
P/OCF 37.93
P/B 1.87
P/tB 9.95
EV/EBITDA 17.87
EPS(TTM)0.06
EY0.77%
EPS(NY)0.25
Fwd EY3.23%
FCF(TTM)0.19
FCFY2.49%
OCF(TTM)0.2
OCFY2.64%
SpS1.55
BVpS4.14
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.36
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 1.08%
ROCE 4.19%
ROIC 2.86%
ROICexc 4.95%
ROICexgc N/A
OM 12.47%
PM (TTM) 2.88%
GM 80.92%
FCFM 12.41%
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.13
Debt/EBITDA 0.05
Cap/Depr 7.67%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 59.17%
Profit Quality 430.43%
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 3.48
F-Score3
WACC8.64%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-0.8%
EPS Next 2Y88.97%
EPS Next 3Y71.24%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.02%
Revenue Next 2Y38.73%
Revenue Next 3Y27.64%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.11%
EBIT Next 3Y40.24%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A

VITALHUB CORP / VHI.CA FAQ

What is the fundamental rating for VHI stock?

ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.


What is the valuation status of VITALHUB CORP (VHI.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for VITALHUB CORP?

VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.


Can you provide the financial health for VHI stock?

The financial health rating of VITALHUB CORP (VHI.CA) is 6 / 10.